Eubel Brady & Suttman Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-71,726
Closed -$18.8M 113
2025
Q2
$18.8M Buy
71,726
+904
+1% +$220K 2.38% 21
2025
Q1
$16.5M Buy
+70,822
New +$17.2M 2.17% 20
2024
Q2
Sell
-110,650
Closed -$24.2M 98
2024
Q1
$24.2M Buy
110,650
+43,369
+64% +$9.55M 3.08% 11
2023
Q4
$15.3M Buy
67,281
+892
+1% +$187K 2.03% 26
2023
Q3
$13.3M Sell
66,389
-3,875
-6% -$817K 1.95% 27
2023
Q2
$14.6M Buy
70,264
+1,498
+2% +$291K 2.01% 26
2023
Q1
$13.6M Buy
68,766
+2,318
+3% +$477K 1.97% 25
2022
Q4
$13.4M Buy
66,448
+1,493
+2% +$292K 2.16% 21
2022
Q3
$11.4M Buy
64,955
+3,810
+6% +$780K 2.04% 24
2022
Q2
$12.3M Buy
61,145
+1,730
+3% +$369K 2.46% 22
2022
Q1
$13.5M Buy
59,415
+1,723
+3% +$405K 2.47% 20
2021
Q4
$15.6M Buy
57,692
+392
+0.7% +$97K 3.05% 15
2021
Q3
$13.9M Sell
57,300
-1,065
-2% -$268K 2.88% 19
2021
Q2
$12.8M Sell
58,365
-58,366
-50% -$13.3M 1.12% 23
2021
Q1
$25.6M Buy
116,731
+54,806
+89% +$11M 2.79% 20
2020
Q4
$10.8M Sell
61,925
-1,892
-3% -$327K 2.6% 20
2020
Q3
$10.3M Buy
63,817
+151
+0.2% +$23.9K 2.75% 18
2020
Q2
$9.09M Sell
63,666
-310
-0.5% -$42.9K 2.39% 23
2020
Q1
$6.95M Buy
+63,976
New +$9.22M 2.08% 25

Other funds holding LH

Eubel Brady & Suttman Asset Management's LH Position: Q3 2025 in Review

Eubel Brady & Suttman Asset Management sold out of Labcorp (LH) in Q3 2025, closing a stake of 71,726 shares — an estimated $18.8M sold.

Eubel Brady & Suttman Asset Management first reported a position in LH in Q1 2020 and held it in 19 quarters. The position peaked at $25.6M in Q1 2021. 1,009 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Eubel Brady & Suttman Asset Management reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
  • Eubel Brady & Suttman Asset Management sold 71,726 Labcorp shares in Q3 2025, an estimated $18.8M.
  • Eubel Brady & Suttman Asset Management first reported a position in Labcorp in Q1 2020 and held it in 19 quarters.
  • Eubel Brady & Suttman Asset Management's Labcorp position peaked at $25.6M in Q1 2021.
  • 1,009 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.